1
|
Hussein M, Gallais F, Dégot T, Hirschi S, Leroux J, Riou M, Stauder J, Falcoz PE, Olland A, Kessler R, Renaud-Picard B. Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study. Respir Med Res 2024; 85:101100. [PMID: 38657294 DOI: 10.1016/j.resmer.2024.101100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2023] [Revised: 01/19/2024] [Accepted: 03/01/2024] [Indexed: 04/26/2024]
Abstract
INTRODUCTION Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2. METHODS We used clinical and paraclinical data collected during routine follow-up. A questionnaire was submitted to each patient at each period to assess their lifestyle, adherence to protective measures against COVID-19, contacts with their family and friends, and contagion risk. The incidence of new COVID-19 cases was also assessed. RESULTS Overall, 283 LT and 57 RLD patients were included. We observed only eight COVID-19 cases over the three periods (n = 4 during T1, n = 0 during T2, and n = 4 during T3) in LT patients, with 37.5 % of patients hospitalized, no ICU transfers, and 100 % favorable outcomes. No case of COVID-19 was diagnosed in the RLD cohort. When comparing the three periods in the LT group, fewer patients limited their out-of-home activities during T2 (p < 0.0001). The frequency of these activities increased after the first lockdown, for the purchase of basic necessities (p < 0.0001), and professional activity continued (p = 0.008). We observed a significant increase in unscheduled medical consultations and in the prescription of anti-infective treatments during the end of the lockdown (p = 0.0002 and p = 0.005, respectively). Adherence to lockdown and to protective measures was high in both groups of patients. CONCLUSION COVID-19 incidence remained low in both groups and there were significant lifestyle evolutions in LT patients and in those with RLD between first and second lockdown.
Collapse
Affiliation(s)
- Moustapha Hussein
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Floriane Gallais
- Laboratory of Virology, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Tristan Dégot
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Sandrine Hirschi
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Justine Leroux
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Marianne Riou
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Julien Stauder
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Pierre-Emmanuel Falcoz
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Anne Olland
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Romain Kessler
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France; INSERM UMR 1260 - Regenerative nanomedicine, Université de Strasbourg, Strasbourg, France
| | - Benjamin Renaud-Picard
- Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France; INSERM UMR 1260 - Regenerative nanomedicine, Université de Strasbourg, Strasbourg, France.
| |
Collapse
|
2
|
Hatzikiriakidis K, West S, Ayton D, Morris H, Martin RS, Paraskeva M. When immunosuppression and COVID-19 intersect: An exploratory qualitative study of young lung transplant recipient perceptions of daily life during a pandemic. Pediatr Transplant 2022; 26:e14281. [PMID: 35427443 PMCID: PMC9115456 DOI: 10.1111/petr.14281] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Accepted: 03/28/2022] [Indexed: 01/27/2023]
Abstract
BACKGROUND The COVID-19 pandemic poses an increased risk of infection, severe illness, hospitalization and mortality for young people who are immunosuppressed, including lung transplant (LTx) recipients. The aim of this study was to explore the intersection between immunosuppression and COVID-19, through the impacts of the pandemic upon the daily lives of young LTx recipients residing in the Australian state of Victoria. METHODS An exploratory qualitative research study was undertaken via consumer engagement. A purposive sample of 11 LTx recipients, residing in Victoria, was recruited during the first year of the COVID-19 pandemic. Semi-structured interviews were conducted to gain insights into their daily life and healthcare experiences, including the impacts of the COVID-19 pandemic. Data were interpreted using thematic analysis. RESULTS Four major themes were identified: (1) occupational deprivation due to the intersection of COVID-19 and lung transplant; (2) resilience and acceptance of restrictions; (3) infection control and vigilance about risk; and (4) care experiences of telehealth. CONCLUSIONS Occupational deprivation emerged as a common theme, specifically in the context of loss of access to meaningful everyday activities of developmental significance. However, participants also commonly reflected upon their ability to flexibly adjust to changing socially regulated community and healthcare environments. A high degree of acceptance and compliance with public health orders was self-reported, may be indicative of this cohort's long-term experience of chronic illness and their understanding of the importance of minimizing infection risks. Youth-informed healthcare strategies were identified as keystone to engaging them in institutional change and program adaptation during a pandemic.
Collapse
Affiliation(s)
- Kostas Hatzikiriakidis
- Health and Social Care UnitSchool of Public Health and Preventive MedicineFaculty of Medicine, Nursing, and Health SciencesMonash UniversityMelbourneVictoriaAustralia
| | - Simone West
- Department of Occupational TherapyNational Paediatric Lung‐Heart Transplant ServiceAlfred HealthMelbourneVictoriaAustralia
| | - Darshini Ayton
- Health and Social Care UnitSchool of Public Health and Preventive MedicineFaculty of Medicine, Nursing, and Health SciencesMonash UniversityMelbourneVictoriaAustralia
| | - Heather Morris
- Health and Social Care UnitSchool of Public Health and Preventive MedicineFaculty of Medicine, Nursing, and Health SciencesMonash UniversityMelbourneVictoriaAustralia
| | - Rani S. Martin
- Department of Allergy, Immunology, and Respiratory MedicineAlfred HospitalMonash UniversityMelbourneVictoriaAustralia
| | - Miranda Paraskeva
- Department of Allergy, Immunology, and Respiratory MedicineAlfred HospitalMonash UniversityMelbourneVictoriaAustralia,Central Clinical SchoolFaculty of Medicine, Nursing, and Health SciencesMonash UniversityMelbourneVictoriaAustralia
| |
Collapse
|
3
|
Renaud-Picard B, Gallais F, Riou M, Chatron E, Degot T, Freudenberger S, Porzio M, Schuller A, Stauder J, Hirschi S, Kessler R. The social and clinical impact of the COVID-19 epidemic on the Strasbourg lung transplant cohort: A single-center retrospective cohort study. Clin Transplant 2020; 34:e14119. [PMID: 33048391 PMCID: PMC7646014 DOI: 10.1111/ctr.14119] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 09/12/2020] [Accepted: 09/30/2020] [Indexed: 12/11/2022]
Abstract
The clinical and social impacts of the COVID-19 epidemic on lung transplant (LTx) recipients remain poorly known. We aimed to evaluate its social, clinical, and behavioral consequences on the LTx patients followed in Strasbourg university hospital. A questionnaire was used to collect details concerning patients' lifestyles, their protection methods used to avoid COVID-19 contamination, and clinical infection-related information for March 2020. A specific score was created to quantify patients' contacts and the associated risk of infectious contagion. Data were collected from 322 patients (91.2%). A majority reported a higher application than usual of social distancing and barrier measures. 43.8% described infectious-related symptoms and 15.8% needed an anti-infective treatment. There was no difference in symptom onset according to age, native lung disease, diabetes, or obesity. Nineteen patients were tested for COVID-19, and four were diagnosed positive, all with a favorable outcome. The infection risk contact score was higher for symptomatic patients (p: 0.007), those needing extra-medical appointments (p < .001), and those receiving anti-infective treatments (p = .02). LTx patients reported a careful lifestyle and did not seem at higher risk for COVID-19. Our score showed encouraging preliminary results and could become a useful tool for the usual infection-related follow-up of the LTx patients.
Collapse
Affiliation(s)
- Benjamin Renaud-Picard
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France.,Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France
| | - Floriane Gallais
- Laboratory of Virology, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Marianne Riou
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France.,Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France
| | - Eva Chatron
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France.,Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France
| | - Tristan Degot
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Sophie Freudenberger
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Michele Porzio
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France.,Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France
| | - Armelle Schuller
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Julien Stauder
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Sandrine Hirschi
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France
| | - Romain Kessler
- Respiratory Medicine and Strasbourg Lung Transplant Program, Hôpitaux universitaires de Strasbourg, Strasbourg, France.,Faculty of Medicine, Federation of Translational Medicine (FMTS), Strasbourg, France
| |
Collapse
|